Gracell Biotechnologies Inc (DELISTED) (GRCL:DL)
10.25
0.00 (0.00%)
USD |
NASDAQ |
Feb 22, 16:00
Gracell Biotechnologies Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -2.283M |
| June 30, 2022 | 4.812M |
| June 30, 2021 | 223.69M |
| Date | Value |
|---|---|
| September 30, 2020 | 9.148M |
| September 30, 2019 | 56.27M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.283M
Minimum
Jun 2023
223.69M
Maximum
Jun 2021
58.33M
Average
9.148M
Median
Sep 2020
Cash from Financing (Quarterly) Benchmarks
| RayzeBio inc (DELISTED) | 314.84M |
| Zai Lab Ltd | 0.393M |
| WuXi Biologics (Cayman) Inc | -- |
| Axonics Inc | 0.578M |
| I-MAB | -- |